92 related articles for article (PubMed ID: 11780577)
21. [Alcohol dehydrogenase and aldehyde dehydrogenase as tumour markers and factors intensifying carcinogenesis in colorectal cancer].
Jelski W; Orywal K; Kedra B; Szmitkowski M
Pol Merkur Lekarski; 2008 Jun; 24(144):506-10. PubMed ID: 18702331
[TBL] [Abstract][Full Text] [Related]
22. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
26. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
Kruszewski WJ; Rzepko R; Wojtacki J; Skokowski J; Kopacz A; Jaśkiewicz K; Drucis K
Neoplasma; 2004; 51(1):38-43. PubMed ID: 15004658
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical investigations of cathepsin D activity in the structures of cholesteatoma.
Chodynicki S; Chyczewski L; Olszewska E
Med Sci Monit; 2002 May; 8(5):BR184-6. PubMed ID: 12011767
[TBL] [Abstract][Full Text] [Related]
29. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.
Odin E; Wettergren Y; Nilsson S; Willén R; Carlsson G; Spears CP; Larsson L; Gustavsson B
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6012-9. PubMed ID: 14676127
[TBL] [Abstract][Full Text] [Related]
30. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast.
Fernandez-Aguilar S; Noël JC
APMIS; 2008 Jan; 116(1):33-40. PubMed ID: 18254778
[TBL] [Abstract][Full Text] [Related]
31. [Cathepsin D activity in human ovarian carcinoma].
Reich W; Wagner F; Hofmann KD; Marzotko F; Schmeisser G
Zentralbl Gynakol; 1984; 106(3):196-200. PubMed ID: 6702349
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin D content in colorectal cancer. Correlation with cathepsin D activity and other biological parameters: a preliminary report.
Tumminello FM; Gebbia N; Pizzolanti G; Russo A; Bazan V; Leto G
Oncology; 1995; 52(3):237-42. PubMed ID: 7715907
[TBL] [Abstract][Full Text] [Related]
33. Protein expression of the chemokine, CCL28, in human colorectal cancer.
Dimberg J; Hugander A; Wågsäter D
Int J Oncol; 2006 Feb; 28(2):315-9. PubMed ID: 16391784
[TBL] [Abstract][Full Text] [Related]
34. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
35. [The effect of mefenamic acid on the immunity indices and hemostatic system in cancer patients and on the cathepsin D-like protease activity in the tissues in cancer of the large intestine].
Kliachkin BM; Basargin ST; Timofeev IV; Khaliulin IuG; Dorofeev SA; Alekseenko LD; Gumeniuk ML
Vopr Onkol; 1992; 38(7):792-7. PubMed ID: 1338673
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical visualisation of cathepsin-D expression in breast cancer.
Barthell E; Mylonas I; Shabani N; Kunze S; Kuhn C; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2035-9. PubMed ID: 17649818
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferases activity in patients with colorectal cancer.
Nomani H; Ghobadloo SM; Yaghmaei B; Rezvanie NA; Yaghmaei K
Clin Biochem; 2005 Jul; 38(7):621-4. PubMed ID: 15904910
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
39. The impact of tumor location on the histopathologic expression of colorectal cancer.
Papagiorgis P; Oikonomakis I; Karapanagiotou I; Wexner SD; Nikiteas N
J BUON; 2006; 11(3):317-21. PubMed ID: 17309156
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
